Duopharma Biotech Berhad (7148.KL)

MYR 1.24

(-0.8%)

Operating Income Summary of Duopharma Biotech Berhad

  • Duopharma Biotech Berhad's latest annual operating income in 2023 was 80.87 Million MYR , down -12.96% from previous year.
  • Duopharma Biotech Berhad's latest quarterly operating income in 2024 Q2 was 27.33 Million MYR , up 3.31% from previous quarter.
  • Duopharma Biotech Berhad reported an annual operating income of 92.91 Million MYR in 2022, up 4.68% from previous year.
  • Duopharma Biotech Berhad reported an annual operating income of 88.75 Million MYR in 2021, up 8.43% from previous year.
  • Duopharma Biotech Berhad reported a quarterly operating income of 27.33 Million MYR for 2024 Q2, up 3.31% from previous quarter.
  • Duopharma Biotech Berhad reported a quarterly operating income of 16.69 Million MYR for 2023 Q3, down -19.09% from previous quarter.

Annual Operating Income Chart of Duopharma Biotech Berhad (2023 - 2006)

Historical Annual Operating Income of Duopharma Biotech Berhad (2023 - 2006)

Year Operating Income Operating Income Growth
2023 80.87 Million MYR -12.96%
2022 92.91 Million MYR 4.68%
2021 88.75 Million MYR 8.43%
2020 81.85 Million MYR 5.42%
2019 77.64 Million MYR 18.93%
2018 65.28 Million MYR 20.18%
2017 54.32 Million MYR 65.64%
2016 32.79 Million MYR -34.65%
2015 50.18 Million MYR 7.29%
2014 46.77 Million MYR 16.39%
2013 40.18 Million MYR 12.89%
2012 35.59 Million MYR 2.9%
2011 34.59 Million MYR -0.93%
2010 34.91 Million MYR -7.58%
2009 37.78 Million MYR 8.14%
2008 34.93 Million MYR -14.68%
2007 40.95 Million MYR 11.75%
2006 36.64 Million MYR 0.0%

Peer Operating Income Comparison of Duopharma Biotech Berhad

Name Operating Income Operating Income Difference
Kotra Industries Berhad 49.39 Million MYR -63.728%